Publikationen in Zusammenarbeit mit Forschern von Lund University (32)

2021

  1. Machine learning risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: The COVIDSurg mortality score

    British Journal of Surgery, Vol. 19, Núm. 4

2020

  1. Genomic arrays identify high-risk chronic lymphocytic leukemia with genomic complexity: A multi-center study

    Haematologica, Vol. 105, Núm. 5

2019

  1. Exome sequencing identifies germline variants in DIS3 in familial multiple myeloma

    Leukemia

  2. Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)

    European Journal of Immunology, Vol. 49, Núm. 10, pp. 1457-1973

  3. Severe asthma: Entering an era of new concepts and emerging therapies: Highlights of the 4th international severe asthma forum, Madrid, 2018

    Allergy: European Journal of Allergy and Clinical Immunology

  4. Systemic manifestations of primary Sjögren's syndrome out of the ESSDAI classification: Prevalence and clinical relevance in a large international, multi-ethnic cohort of patients

    Clinical and Experimental Rheumatology, Vol. 37, pp. S97-S106

  5. The Big Data Sjögren consortium: A project for a new data science era

    Clinical and Experimental Rheumatology, Vol. 37, pp. S19-S23

2018

  1. Evaluating Sex and Age Differences in ADI-R and ADOS Scores in a Large European Multi-site Sample of Individuals with Autism Spectrum Disorder

    Journal of Autism and Developmental Disorders, Vol. 48, Núm. 7, pp. 2490-2505

  2. How immunological profile drives clinical phenotype of primary Sjögren's syndrome at diagnosis: Analysis of 10,500 patients (Sjögren Big Data Project)

    Clinical and Experimental Rheumatology, Vol. 36, pp. S102-S111

2017

  1. A multicentric study to evaluate the use of relative retention times in targeted proteomics

    Journal of Proteomics, Vol. 152, pp. 138-149

  2. Impact of prior therapy on the efficacy and safety of oral ixazomiblenalidomide-dexamethasone vs. Placebo-lenalidomide-dexamethasone in patients with relapsed/refractory multiple myeloma in TOURMALINE-MM1

    Haematologica, Vol. 102, Núm. 10, pp. 1767-1775

  3. Is good clinical practice becoming poor clinical care?

    HemaSphere

  4. Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: A multicenter IMWG study

    Leukemia, Vol. 31, Núm. 11, pp. 2443-2448

2016

  1. Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

    Autophagy

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Autophagy, Vol. 12, Núm. 1, pp. 1-222

2015

  1. Association of chromosome 19 to lung cancer genotypes and phenotypes

    Cancer and Metastasis Reviews, Vol. 34, Núm. 2, pp. 217-226

  2. Erratum to: Association of chromosome 19 to lung cancer genotypes and phenotypes [Cancer and Metastasis Review, DOI 10.1007/s10555-015-9556-2]

    Cancer and Metastasis Reviews

  3. Germline mutation in BRCA1 or BRCA2 and ten-year survival for women diagnosed with epithelial ovarian cancer

    Clinical Cancer Research, Vol. 21, Núm. 3, pp. 652-657

  4. In vitro transcription/translation system: A versatile tool in the search for missing proteins

    Journal of Proteome Research, Vol. 14, Núm. 9, pp. 3441-3451

  5. Integration of proteomics and transcriptomics data sets for the analysis of a lymphoma B-cell line in the context of the chromosome-centric human proteome project

    Journal of Proteome Research, Vol. 14, Núm. 9, pp. 3530-3540